skip navigation
National Criminal Justice Reference Service
Login | Subscribe/Register | Manage Account | Shopping Cartshopping cart icon | Help | Contact Us | Home     
National Criminal Justice Reference Service
  Advanced Search
Search Help
     
| | | | |
place holder
Administered by the Office of Justice Programs U.S. Department of Justice Office of Justice Programs Seal National Criminal Justice Reference Service National Criminal Justice Reference Service Office of Justice Programs Seal National Criminal Justice Reference Service
Topics
A-Z Topics
Corrections
Courts
Crime
Crime Prevention
Drugs
Justice System
Juvenile Justice
Law Enforcement
Victims
Left Nav Bottom Line
Home / NCJRS Abstract

Publications
 

NCJRS Abstract


The document referenced below is part of the NCJRS Library collection.
To conduct further searches of the collection, visit the NCJRS Abstracts Database.

How to Obtain Documents
 
NCJ Number: NCJ 226970  Add to Shoppping Cart
Title: ADAM II 2007 Annual Report: Arrestee Drug Abuse Monitoring Program II
Corporate Author: Abt Associates, Inc
United States
Sponsoring Agency: Office of National Drug Control Policy
United States
Sale: NCJRS Photocopy Services
Box 6000
Rockville, MD 20849-6000
United States

Office of National Drug Control Policy
Old Executive Office Building
Washington, DC 20500
United States
Agency Summary Url: Agency Summary 
Document Url: PDF 
Publication Date: 04/2008
Pages: 143
Type: Annual/periodic reports/yearbooks
Origin: United States
Language: English
Contract No.: GS-10F-0086K
Annotation: This 2007 ADAM (Arrestee Drug Abuse Monitoring) II Annual Report presents information on the ADAM II program, comparing it to the former ADAM program; presents findings on drug use among booked adult male arrestees for the 10 ADAM II sites; presents the demographics of the arrestee population; supplies information on arrestee treatment experiences; and provides information on local drug markets.
Abstract: ADAM II continues the original ADAM methodology while broadening its focus on collecting valid and reliable information on the possible spread of methamphetamine into new areas of the Nation after 2003. ADAM II continues the goal of ADAM in being a vital source of data for estimating trends in drug use in local areas, revealing the connection between drugs and crime, and describing drug-market behavior among adult male arrestees. The ADAM II data were collected from face-to-face interviews with arrestees and the collection of a urine sample for testing within 48 hours of their arrests. The 2007 data were collected for the 10 former ADAM sites: Atlanta, GA; Charlotte, NC; Chicago, IL; Denver, CO; Indianapolis, IN; Minneapolis, MN; New York, NY; Portland, OR; Sacramento, CA; and Washington, DC. A total of 4,334 booked arrestees voluntarily completed interviews, a response rate of 52 percent; 77 percent (3,345) of those interviewed provided urine samples for testing. Samples were tested for 10 drugs: marijuana, cocaine, opiates, amphetamines/methamphetamine, propoxyphene, phencyclidine, benzodiazepines, methadone, barbiturates, and oxycodone. Detection thresholds were the same as in ADAM. Across the 10 ADAM II sites in 2007, just over two-thirds of arrestees interviewed in each site tested positive for at least 1 illicit drug at the time of arrest. These levels are consistent with results among arrestees in 9 of the same 10 sites in 2003, with a statistically significant decrease in only the Sacramento site. 28 tables, 5 exhibits, 12 figures, and appended ADAM II program methodology and fact sheets for each site
Main Term(s): Drug use
Index Term(s): Marijuana ; Opiates ; Amphetamines ; Cocaine ; Drug treatment ; Drug testing ; Trend analysis ; Offender profiles ; Arrest procedures ; Self-report studies ; Methamphetamines
 
To cite this abstract, use the following link:
http://www.ncjrs.gov/App/Publications/abstract.aspx?ID=248969

* A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's web site is provided.


Contact Us | Feedback | Site Map
Freedom of Information Act | Privacy Statement | Legal Policies and Disclaimers | USA.gov

U.S. Department of Justice | Office of Justice Programs | Office of National Drug Control Policy

place holder